Kingdom Capital
Kingdom Capital is a venture capital and private equity firm established in 2016, located in Chesterfield, Missouri. The firm focuses on early and growth-stage investments in mature and established companies across various sectors, including healthcare, technology, media, and real estate. It emphasizes sectors such as artificial intelligence, data science, therapeutics, medical devices, diagnostics, healthcare IT, and life science tools. Kingdom Capital aims to create a values-driven ecosystem that connects its investors with impactful investment opportunities, fostering collaboration with philanthropic partners through its Kingdom Capital Foundation. This strategic integration enhances the flow of capital into the philanthropic community, supporting both financial and social returns.
Canopy Biosciences
Series A in 2018
Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.